12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
週三盤後交易時段，12只醫療保健類股走勢
Gainers
獲勝者
- Bone Biologics (NASDAQ:BBLG) stock moved upwards by 56.0% to $0.81 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 2.3 million shares, which is 878.8 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $2.5 million. The company's, Q3 earnings came out yesterday.
- Exagen (NASDAQ:XGN) stock rose 15.78% to $1.76. The market value of their outstanding shares is at $29.6 million. As per the press release, Q3 earnings came out 2 days ago.
- PAVmed (NASDAQ:PAVM) shares increased by 11.31% to $0.25. The company's market cap stands at $27.4 million. As per the news, the Q3 earnings report came out yesterday.
- GRI Bio (NASDAQ:GRI) shares rose 9.9% to $1.22. The market value of their outstanding shares is at $3.6 million.
- Surrozen (NASDAQ:SRZN) shares rose 6.2% to $0.4. The company's market cap stands at $12.3 million.
- Heart Test Laboratories (NASDAQ:HSCS) shares increased by 6.0% to $0.16. Trading volume for this security closed at 31.8 million, accounting for 1722.0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.7 million.
- 在週三的盤後交易中，Bone Biologics（納斯達克股票代碼：BBLG）股價上漲56.0％，至0.81美元。該證券今天的交易量最終收於230萬股，佔其過去100天平均交易量的878.8％。他們流通股的市值爲250萬美元。該公司昨天公佈了第三季度的收益。
- Exagen（納斯達克股票代碼：XGN）股價上漲15.78％，至1.76美元。他們流通股的市值爲2960萬美元。根據新聞稿，第三季度業績是在兩天前發佈的。
- PavMed（納斯達克股票代碼：PAVM）股價上漲11.31％，至0.25美元。該公司的市值爲2740萬美元。根據消息，第三季度收益報告於昨天發佈。
- GRI Bio（納斯達克股票代碼：GRI）股價上漲9.9％，至1.22美元。他們流通股的市值爲360萬美元。
- Surrozen（納斯達克股票代碼：SRZN）股價上漲6.2％，至0.4美元。該公司的市值爲1,230萬美元。
- 心臟測試實驗室（納斯達克股票代碼：HSCS）股價上漲6.0％，至0.16美元。該證券的交易量收於3180萬，佔其過去100天平均全日交易量的1722.0％。該公司的市值爲170萬美元。
Losers
失敗者
- Augmedix (NASDAQ:AUGX) shares decreased by 20.8% to $4.3 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 66.5K shares, which is 29.6 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $175.4 million.
- Impel Pharmaceuticals (NASDAQ:IMPL) shares declined by 15.94% to $0.24. The market value of their outstanding shares is at $5.5 million.
- OpGen (NASDAQ:OPGN) stock declined by 9.34% to $0.44. The company's market cap stands at $4.7 million. As per the press release, Q3 earnings came out yesterday.
- Autolus Therapeutics (NASDAQ:AUTL) shares declined by 9.2% to $3.85. The market value of their outstanding shares is at $669.8 million.
- Baudax Bio (NASDAQ:BXRX) stock decreased by 8.66% to $0.17. The market value of their outstanding shares is at $1.5 million.
- Cocrystal Pharma (NASDAQ:COCP) shares fell 8.29% to $1.66. The company's market cap stands at $16.8 million. As per the news, the Q3 earnings report came out 2 days ago. See Also:
- 在週三的盤後交易中，Augmedix（納斯達克股票代碼：AUGX）股價下跌20.8％，至4.3美元。該證券今天的交易量最終收於66.5萬股，佔其過去100天平均交易量的29.6％。他們流通股的市值爲1.754億美元。
- 英佩爾製藥（納斯達克股票代碼：IMPL）股價下跌15.94％，至0.24美元。他們流通股的市值爲550萬美元。
- OpGen（納斯達克股票代碼：OPGN）股價下跌9.34％，至0.44美元。該公司的市值爲470萬美元。根據新聞稿，第三季度業績於昨天公佈。
- Autolus Therapeutics（納斯達克股票代碼：AUTL）股價下跌9.2％，至3.85美元。他們流通股的市值爲6.698億美元。
- Baudax Bio（納斯達克股票代碼：BXRX）股價下跌8.66％，至0.17美元。他們流通股的市值爲150萬美元。
- Cocrystal Pharma（納斯達克股票代碼：COCP）股價下跌8.29％，至1.66美元。該公司的市值爲1,680萬美元。根據消息，第三季度收益報告是在2天前發佈的。另見：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。